{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:05:29Z","timestamp":1790417129215,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","award":["MOP-136778"],"award-info":[{"award-number":["MOP-136778"]}],"id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12035-019-01714-6","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T16:03:06Z","timestamp":1565020986000},"page":"492-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Interaction Between Neuroinflammation and \u03b2-Amyloid in Cognitive Decline in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Christine","family":"Ghadery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Koshimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-0974","authenticated-orcid":false,"given":"Antonio P.","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AHV, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245 \nhttp:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442206703738\n\n. Accessed November 4, 2018","journal-title":"Lancet Neurol"},{"key":"1714_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, M\u00fcller MLTM, Albin RL, Frey KA (2015) Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov Disord 30:928\u2013935","journal-title":"Mov Disord"},{"key":"1714_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M et al (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106:518\u2013526 \nhttp:\/\/link.springer.com\/10.1007\/s00401-003-0766-2\n\n. Accessed November 4, 2018","journal-title":"Acta Neuropathol"},{"key":"1714_CR4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/mp.2015.1","volume":"20","author":"I Suridjan","year":"2015","unstructured":"Suridjan I, Pollock BG, Verhoeff NPLG, Voineskos AN, Chow T, Rusjan PM, Lobaugh NJ, Houle S et al (2015) In-vivo imaging of grey and white matter neuroinflammation in Alzheimer\u2019s disease: a positron emission tomography study with a novel radioligand, \u201c18 F\u201d-FEPPA. Mol Psychiatry 20:1579\u20131587","journal-title":"Mol Psychiatry"},{"key":"1714_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison P, Ahmed I, Fan Z et al (2013) Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology 38:938\u2013949 \nhttp:\/\/www.nature.com\/articles\/npp2012255\n\n. Accessed November 4, 2018","journal-title":"Neuropsychopharmacology"},{"key":"1714_CR6","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA et al (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245\u20134249 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3159021\n\n. Accessed November 4, 2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1714_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/mds.10295","volume":"18","author":"FL Mastaglia","year":"2003","unstructured":"Mastaglia FL, Johnsen RD, Byrnes ML et al (2003) Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson\u2019s disease. Mov Disord 18:81\u201386 \nhttp:\/\/doi.wiley.com\/10.1002\/mds.10295\n\n. Accessed November 4, 2018","journal-title":"Mov Disord"},{"key":"1714_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","volume":"79","author":"M Petrou","year":"2012","unstructured":"Petrou M, Bohnen NI, Muller MLTM et al (2012) Abeta-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 79:1161\u20131167 \nhttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3525303&tool=pmcentrez&rendertype=abstract","journal-title":"Neurology"},{"key":"1714_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/WNL.0b013e31826e2696","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Roberts RO, Geda YE, Swenson-Dravis DM et al (2012) Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 79:1570\u20131577","journal-title":"Neurology."},{"key":"1714_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O'Keefe G et al (2008) Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331\u20131338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1714_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","volume":"80","author":"SN Gomperts","year":"2013","unstructured":"Gomperts SN, Locascio JJ, Rentz D et al (2013) Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 80:85\u201391 7p. Accessed at: \nhttp:\/\/search.ebscohost.com\/login.aspx?direct=true&db=ccm&AN=108089057&site=ehost-live","journal-title":"Neurology"},{"key":"1714_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-013-1182-x","volume":"126","author":"S Prokop","year":"2013","unstructured":"Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer\u2019s disease. Acta Neuropathol 126:461\u2013477 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24224195\n\n. Accessed November 4, 2018","journal-title":"Acta Neuropathol"},{"key":"1714_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349\u2013356 \nhttp:\/\/doi.wiley.com\/10.1002\/mds.24893\n\n. Accessed October 1, 2018","journal-title":"Mov Disord"},{"key":"1714_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","volume":"35","author":"AA Wilson","year":"2008","unstructured":"Wilson AA, Garcia A, Parkes J et al (2008) Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35:305\u2013314 \nhttp:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805108000073\n\n. Accessed November 4, 2018","journal-title":"Nucl Med Biol"},{"key":"1714_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis CA, Bacskai BJ, Kajdasz ST et al (2002) A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett 12:295\u2013298 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11814781\n\n. Accessed November 4, 2018","journal-title":"Bioorg Med Chem Lett"},{"key":"1714_CR16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","volume":"31","author":"PM Rusjan","year":"2011","unstructured":"Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, Mizrahi R (2011) Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab 31:1807\u20131816 \nhttp:\/\/journals.sagepub.com\/doi\/10.1038\/jcbfm.2011.55\n\n. Accessed October 1, 2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"1714_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F, Tetsuya S, Houle S et al (2006) An automated method for the extraction of regional data from PET images. Psychiatry Res - Neuroimaging 147:79\u201389","journal-title":"Psychiatry Res - Neuroimaging"},{"key":"1714_CR18","first-page":"402","volume":"45","author":"B Bencherif","year":"2004","unstructured":"Bencherif B, Stumpf MJ, Links JM et al (2004) Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med 45:402\u2013408 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15001679\n\n. Accessed November 4, 2018","journal-title":"J Nucl Med"},{"key":"1714_CR19","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA et al (2005) Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46:1959\u20131972 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16330558\n\n. Accessed October 1, 2018","journal-title":"J Nucl Med"},{"key":"1714_CR20","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/awv112","volume":"138","author":"S Villeneuve","year":"2015","unstructured":"Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, la Joie R, Arthur-Bentil SK et al (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain. 138:2020\u20132033","journal-title":"Brain."},{"key":"1714_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Ch\u00e9telat G et al (2011) Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease. Ann Neurol 69:181\u2013192 \nhttp:\/\/doi.wiley.com\/10.1002\/ana.22248\n\n. Accessed October 1, 2018","journal-title":"Ann Neurol"},{"key":"1714_CR22","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","volume":"19","author":"DK Lahiri","year":"1991","unstructured":"Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444 \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1681511\n\n. Accessed November 4, 2018","journal-title":"Nucleic Acids Res"},{"key":"1714_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/jcbfm.2012.46","volume":"32","author":"R Mizrahi","year":"2012","unstructured":"Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I, de Luca V, Wilson AA et al (2012) Translocator protein (18\u00a0kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [18F]-FEPPA. J Cereb Blood Flow Metab 32:968\u2013972","journal-title":"J Cereb Blood Flow Metab"},{"key":"1714_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","volume":"69","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Couch Y, Richardson J et al (2011) Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci Res 69:337\u2013342 \nhttp:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010211000101\n\n. Accessed November 4, 2018","journal-title":"Neurosci Res"},{"key":"1714_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0177924","volume":"12","author":"RS Akhtar","year":"2017","unstructured":"Akhtar RS, Xie SX, Chen YJ, Rick J, Gross RG, Nasrallah IM, van Deerlin VM, Trojanowski JQ et al (2017) Regional brain amyloid-\u03b2 accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. PLoS One 12:1\u201318. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0177924","journal-title":"PLoS One"},{"key":"1714_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","volume":"11","author":"Z Fan","year":"2015","unstructured":"Fan Z, Aman Y, Ahmed I et al (2015) Influence of microglial activation on neuronal function in Alzheimer\u2019s and Parkinson\u2019s disease dementia. Alzheimers Dement 11:608\u201321.e7 \nhttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1552526014025011\n\n. Accessed November 4, 2018","journal-title":"Alzheimers Dement"},{"key":"1714_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G et al (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21:404\u2013412 \nhttp:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996105002263\n\n. Accessed November 4, 2018","journal-title":"Neurobiol Dis"},{"key":"1714_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.parkreldis.2013.01.017","volume":"19","author":"C Kobylecki","year":"2013","unstructured":"Kobylecki C, Counsell SJ, Cabanel N et al (2013) Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes. Parkinsonism Relat Disord 19:527\u2013532 \nhttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013000527\n\n. Accessed November 4, 2018","journal-title":"Parkinsonism Relat Disord"},{"key":"1714_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/00207454.2013.833510","volume":"124","author":"Z Cai","year":"2014","unstructured":"Cai Z, Hussain MD, Yan LJ (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease. Int J Neurosci 124:307\u2013321","journal-title":"Int J Neurosci"},{"key":"1714_CR30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, Leroy C, Labit M, Comley RA, de Souza LC, Corne H et al (2016) Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using18F-DPA-714 PET imaging. Brain. 139:1252\u20131264","journal-title":"Brain."},{"key":"1714_CR31","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, H\u00e9rard A-S et al (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 32:10809\u201310818 \nhttp:\/\/www.jneurosci.org\/cgi\/doi\/10.1523\/JNEUROSCI.1487-12.2012\n\n. Accessed November 4, 2018","journal-title":"J Neurosci"},{"key":"1714_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","volume":"16","author":"MG Stokholm","year":"2017","unstructured":"Stokholm MG, Iranzo A, \u00d8stergaard K et al (2017) Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol 16:789\u2013796 \nhttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442217301734\n\n. Accessed November 4, 2018","journal-title":"Lancet Neurol"},{"key":"1714_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2018.02.017","volume":"115","author":"MG Stokholm","year":"2018","unstructured":"Stokholm MG, Iranzo A, \u00d8stergaard K et al (2018) Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiol Dis 115:9\u201316 \nhttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118300494\n\n. Accessed November 4, 2018","journal-title":"Neurobiol Dis"},{"key":"1714_CR34","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/brain\/awv184","volume":"138","author":"A Jucaite","year":"2015","unstructured":"Jucaite A, Svenningsson P, Rinne JO, Csel\u00e9nyi Z, Varn\u00e4s K, Johnstr\u00f6m P, Amini N, Kirjavainen A et al (2015) Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson\u2019s disease. Brain 138:2687\u20132700 \nhttps:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awv184\n\n. Accessed November 4, 2018","journal-title":"Brain"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01714-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:59:16Z","timestamp":1596499156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01714-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01714-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declared that they have no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}